CD8A and breast cancer: In addition, intratumor and circulating Th17 cells were associated with improved prognosis and clinical response to therapy in BC [11, 45] and in vivo data suggested the occurrence of a strict cooperation between Th17 cells and CD8+ cytotoxic T lymphocytes in mediating effective anti-tumor immune responses [46].